Relmada Therapeutics, Inc. (RLMD)
4.83
+0.30
(+6.62%)
USD |
NASDAQ |
Dec 31, 16:00
4.825
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Cash from Investing (Quarterly): 6.753M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -1.299M |
| Invivyd, Inc. | 0.00 |
| Arcellx, Inc. | -20.03M |
| Puma Biotechnology, Inc. | 0.506M |
| Sensus Healthcare, Inc. | -0.004M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.722M |
| Free Cash Flow | -39.99M |
| Free Cash Flow Per Share (Quarterly) | -0.2025 |
| Free Cash Flow to Equity (Quarterly) | -6.722M |
| Free Cash Flow to Firm (Quarterly) | -6.722M |
| Free Cash Flow Yield | -26.08% |